Emergo by UL HFR&D Opens Healthcare Product Research and Design Facility in Chicago

Wednesday, October 3, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

Emergo by UL's Chicago Studio to provide state-of-the-art onsite design and development support for medical device manufacturers.

CHICAGO, Oct. 3, 2018 /PRNewswire-PRWeb/ -- Emergo by UL, a healthcare consulting firm specializing in global medical

device and IVD compliance, has just opened a new, state-of-the-art facility to support medical device research and design efforts in downtown Chicago.

Chicago Studio was established by Emergo by UL's Human Factors Research & Design (HFR&D) team, which integrates the consulting groups formerly known as UL–Wiklund and Medical Device Usability. Utilizing Chicago Studio, medical device companies can focus on developing robust and user-centered design concepts for medical devices and related healthcare products and technologies. Establishing the facility in Chicago will also foster close collaboration between local and regional incubators, universities, technology developers and medical device manufacturers.

Chicago Studio provides an 8,000-square-foot facility where clients may consult with Emergo by UL HFR&D experts as well as UL Healthcare professionals on device design issues as well as cybersecurity, interoperability, biocompatibility and electromagnetic compatibility (EMC). The new facility supports product research, development and design for medical devices, combination products, wellness products and medical software such as electronic health record systems.

Clients will have access to on-site HFR&D staff in Chicago as well as remote access to additional medical device human factors and product development experts (e.g., industrial designers, biomedical engineers, technical writers) based in the US, Europe and Japan.

"Our team is poised to help medical device manufacturers deliver products that enable excellent patient and user experiences," says Michael Wiklund, CHFP, MS, General Manager of HFR&D at Emergo by UL. "By helping our clients take a user-centered approach to product design, their finished devices are more likely to satisfy user needs and preferences while also protecting against harmful and unwanted use errors. . "These outcomes are critical to a product's commercial success and, in the case of regulated products such as medical devices, necessary to obtaining clearance and approval from authorities such as the US Food and Drug Administration and European Notified Bodies," Wiklund adds.

In addition to supporting the medical industry, HFR&D staff in Chicago and other sites help companies developing non-medical products such as consumer electronics, home appliances, industrial equipment, software, and websites.

About Human Factors Research & Design

Now a service provided by Emergo by UL, our Human Factors Research & Design (HFR&D) team has extensive experience helping clients bring products to market and ensuring best-in-class user experiences. We view ourselves as part of the solution for making healthcare safer and more effective while also helping clients achieve their commercial goals. UL acquired Wiklund Research & Design in 2012. The consulting practice has grown over 400% during the ensuing six years, reflecting strong demand for its services. In mid-2018, UL acquired Medical Device Usability (based in the UK). The two consulting groups are now fully integrated and delivering services to an international clientele. Learn more about HFR&D.

About Emergo by UL

Emergo by UL is a leading regulatory consulting firm specializing in global medical device and IVD compliance. Our comprehensive solution covers device market compliance, digital health as well as human factors research and design consulting to help you achieve and maintain regulatory and commercial success. With a presence on six continents, we can provide real-time service and on-the-ground expertise. Learn more about Emergo by UL.


SOURCE Emergo by UL

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store